Trial Profile
A Prospective, Randomized Trial to Compare Mono-menotropins Protocol for Controlled Ovarian Stimulation (COS) Versus Recombinant Follicle Stimulating Hormone (rFSH) Protocol on Embryo Quality Parameters in IVF Patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 Aug 2020
Price :
$35
*
At a glance
- Drugs Menotropin (Primary) ; Follitropin alfa
- Indications Infertility
- Focus Therapeutic Use
- 10 Aug 2020 Status changed from recruiting to completed.
- 03 Jun 2016 The protocol has been amended with the change of the comparator drug from Urofollitropin to Follitropin-alfa (Gonal-F) and hence the official title, purpose and treatment table has been amended.
- 03 Jun 2016 Planned End Date changed from 1 Oct 2016 to 1 Jul 2017.